Barclays Introduced Vaccine passports And we showed up to show resistance !! This video was filmed and edited by https://instagram.com/leeroypress?igshid=f5vj6ush6fjq

Many scientists and medical experts have warned that vxing children against CV is both unnecessary and risky in the extreme. The video above features comments by Peter Doshi, Ph.D., made during a June 10, 2021, public hearing by the U.S. F—d & Dr-g Administration's Vx and Related Biological Products Advisory Committee. While Pfizer claims its Vx is 95% effective, this is the relative risk reduction. The absolute risk reduction -- which is far more relevant for public health measures -- is actually less than 1% While benefits from CV Vx in children between the ages of 12 and 15 are rare and short-lived, side effects are common and long-term effects are completely unknown. In the 12-to-15 age group, 75.5% experienced headache, along with a long list of other transient side effects. Serious systemic adverse events occurred in 2.4% of the trial subjects receiving fizer's mR-a Vx. While fizer boasted a 100% efficacy rate in 12- to 15-year-olds, this conclusion is a statistical trick. Fewer than 2% of fully Vx children avoided CV, … 98% of them would not have gotten CV anyway. So, the benefit is small. Even if vxing children were found to reduce infection among adults, it would be unethical and against regulations to do so, because the FDA can only authorize the use of a medical product in a given population if the benefit outweighs the risk in that same population, and in children the benefits do not outweigh the risks.